Cargando…

Vasopressor-Refractory Shock From Clozapine Overdose Treated With Synthetic Angiotensin II Infusion

BACKGROUND: Clozapine is an atypical antipsychotic with potent alpha-adrenergic blocking properties when administered at high dosages, resulting in vasodilatory shock in overdose settings. CASE SUMMARY: A 39-year-old man presented with profound catecholamine- and vasopressin-refractory vasodilatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieruszewski, Patrick M., Nelson, Sarah, Wittwer, Erica D., Leung, Jonathan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491889/ https://www.ncbi.nlm.nih.gov/pubmed/32984826 http://dx.doi.org/10.1097/CCE.0000000000000185

Ejemplares similares

Comment on: Treatment strategies for clozapine-induced hypotension: A systematic review
por: Wieruszewski, Patrick M., et al.
Publicado: (2022)

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
por: Wieruszewski, Patrick M., et al.
Publicado: (2023)

Vasopressor Effect of Indigo Carmine in the Management of Refractory Neurogenic Shock
por: Kurozumi, Natsuko, et al.
Publicado: (2023)

Rhabdomyolysis in Clozapine Overdose
por: Jansman, Frank G. A., et al.
Publicado: (2015)

Effects of Length of Vasopressors Infusion on Mortality
por: Kumar, Vikas, et al.
Publicado: (2019)

Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis
por: Bauer, Seth R., et al.
Publicado: (2023)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Angiotensin II: a new approach for refractory shock management?
por: Kimmoun, Antoine, et al.
Publicado: (2014)

Current use of vasopressors in septic shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2019)

Vasopressors in Septic Shock: The Quest for Refinement
por: Pichamuthu, Kishore
Publicado: (2022)

Refractory Shock from Amlodipine Overdose Overcomed with Hyperinsulinemia
por: Koliastasis, L., et al.
Publicado: (2021)

Angiotensin II Use in Refractory Multisystem Shock: A Case Report
por: Ahmed, Mohamed, et al.
Publicado: (2018)

State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
por: Bloom, Jason E., et al.
Publicado: (2023)

Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)

Fluids or vasopressors for the initial resuscitation of septic shock
por: Macdonald, Stephen, et al.
Publicado: (2022)

Angiotensin in ECMO patients with refractory shock
por: Ostermann, Marlies, et al.
Publicado: (2018)

Comparing effects of intraoperative fluid and vasopressor infusion on intestinal microcirculation
por: Fan, Chia-Ning, et al.
Publicado: (2020)

Propofol/steroids/vasopressors: Propofol infusion syndrome: case report
Publicado: (2021)

Propofol/vasopressors: Propofol-related infusion syndrome: case report
Publicado: (2021)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020)

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020)

Hydrocortisone therapy in a cat with vasopressor‐refractory septic shock and suspected critical illness‐related corticosteroid insufficiency
por: Pisano, Simone R. R., et al.
Publicado: (2017)

Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO()
por: Ives Tallman, Crystal, et al.
Publicado: (2021)

Influence of vasopressor agent in pediatric septic shock mortality
por: Mangia, CMF, et al.
Publicado: (2011)

Does vasopressor therapy have an indication in hemorrhagic shock?
por: Beloncle, François, et al.
Publicado: (2013)

Therapeutic Strategies for High-Dose Vasopressor-Dependent Shock
por: Bassi, Estevão, et al.
Publicado: (2013)

Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016)

Vasopressors: Do they have any role in hemorrhagic shock?
por: Gupta, Babita, et al.
Publicado: (2017)

Vasopressors in septic shock: which, when, and how much?
por: Shi, Rui, et al.
Publicado: (2020)

Adjunctive vasopressors in distributive shock: How soon is early?
por: Garcia, Bruno, et al.
Publicado: (2023)

Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock
por: Wang, Hanyin, et al.
Publicado: (2020)

Use of Multimodal Mechanical Support in Refractory Cardiogenic Shock From Bupropion Overdose
por: Bodker, Kevin, et al.
Publicado: (2023)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
por: Avni, Tomer, et al.
Publicado: (2015)

Outcome of patients with septic shock and high-dose vasopressor therapy
por: Auchet, Thomas, et al.
Publicado: (2017)

Should we start vasopressors very early in septic shock?
por: Ospina-Tascón, Gustavo A., et al.
Publicado: (2020)

The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022)

Early versus delayed vasopressor administration in patients with septic shock
por: Abe, Toshikazu, et al.
Publicado: (2023)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Integrative Genomic–Epigenomic Analysis of Clozapine-Treated Patients with Refractory Psychosis
por: Mayén-Lobo, Yerye Gibrán, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_emuids3vc98reo46d5sla2hjs5